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ABSTRACT
Background Targeted screening for cardiovascu-
lar disease (CVD) can be carried out using existing
data from patient medical records. However, elec-
tronic medical records in UK general practice
contain missing risk factor data for which values
must be estimated to produce risk scores.
Objective To compare two methods of substitut-
ing missing risk factor data; multiple imputation
and the use of default National Health Survey
values.
Methods We took patient-level data from patients
in 70 general practices in Ealing, NorthWest London.
We substituted missing risk factor data using the
two methods, applied two risk scores (QRISK2 and
JBS2) to the data and assessed diﬀerences between
methods.
Results Using multiple imputation, mean CVD
risk scores were similar to those using default
national survey values, a simple method of impu-
tation. There were fewer patients designated as high
risk (>20%) using multiple imputation, although
diﬀerences were again small (10.3% compared with
11.7%; 3.0% compared with 3.4% in women). Agree-
ment in high-risk classiﬁcation between methods
was high (Kappa = 0.91 in men; 0.90 in women).
Conclusions A simple method of substituting
missing risk factor data can produce reliable esti-
mates of CVD risk scores. Targeted screening for
high CVD risk, using pre-existing electronic medi-
cal record data, does not require multiple impu-
tation methods in risk estimation.
Keywords: cardiovascular disease, electronic health
records, health inequalities, primary prevention
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Introduction
Considerable resources have been devoted to reducing
the burden of cardiovascular disease (CVD) in the UK
over the past decade.1 In England, this includes the
National Health Service (NHS) Health Check pro-
gramme, which began in 2008.2 Despite this national
commitment to a ‘universal’ programme, evidence is
growing that a targeted approach to preventionmight
be an eﬀective and cost-eﬀective alternative.3,4 Risk
stratiﬁcation involves deriving a CVD risk score using
pre-existing data from patient medical records. A
frequent problem, however, are missing data. Despite
improvements in recording, there is still incomplete-
ness.5,6When data are incomplete, default valuesmust
be entered to produce the risk score.
We compare twomethods of data imputation; ﬁrst,
risk factor estimates derived from national survey
data. This method is computationally simple and is
used in bespoke CVD prevention software,7 however,
it has a limited evidence base and could create inac-
curacies if local and national risk factor proﬁles diﬀer.
A second option is to generate estimates from local
data usingmultiple imputation.8Multiple imputation
is most eﬀective when missing data are unrelated to
observation characteristics [missing completely at ran-
dom (MCAR)], however, it can also be eﬀective when
the pattern of missing data is dependent on recorded
patient characteristics [missing at random (MAR)].9
Multiple imputation is more computationally diﬃ-
cult, however, and is likely to be sensitive to patient
diﬀerences and maintain the local risk proﬁle within
the imputed data. We compare imputation methods
in both JBS210 and QRISK211 risk scores, analysing
data from a deprived, ethnically diverse population.
We further compare diﬀerences in risk stratiﬁcation
between risk scores concentrating on the practice level
workload.
Methods
Data source
We obtained patient-level data from electronic medi-
cal records in 70 of the 85 general practices in Ealing,
NorthWest London.Datawere extracted as part of the
NHS Health Check programme, using Oberoi primary
prevention software. We used data from the baseline
of the programme,5 extracted betweenDecember 2008
and December 2009. Brieﬂy, data consist of demo-
graphic, anthropometric and clinical data relating to
cardiovascular risk for patients registered in general
practice, aged 35–74 years without diagnosed coronary
heart disease or stroke; Table 1 lists the variables
extracted. We did not have data recorded for rheu-
matoid arthritis. Information on area deprivation is
required for theQRISK2 risk engine, Townsend scores
were linked to patient data using postcode of resi-
dence. We also linked 2007 Index of Multiple Depri-
vation (IMD) scores to data for the analyses. Data
represent a patient’s latest record at the time of
extraction. We discounted data older than 15 years,
because complete dataweremore important than timely
data. The majority of data records were, however, from
the previous ﬁve years.
The data contained missing values for a number of
variables (Table 1). For both methods of imputation,
we entered patients withmissing ethnicity records as a
subgroup in the analysis; for deprivation we replaced
the missing Townsend score with the primary care
trust (PCT) median. For rheumatoid arthritis, we
assumed the condition to be absent if missing, in line
with guidance for the QRISK2 score,11 as were chronic
kidney disease (CKD) and a family history of CVD.
Weused twomethods to estimate values formissing
blood pressure, total cholesterol, high-density lipo-
protein (HDL), body mass index (BMI) and smoking
status. First, we used multiple imputation, using the
uvis commands in Stata, generating 10 imputed data-
sets (m). We used multi-level linear imputation models
(logistic regression for smoking status) to impute
missing values. Level one of the model was the patient
and level two was the general practice. Variables entered
into models are shown in Table 1, with the addition of
interaction terms between sex and age, and sex and
ethnicity. We calculated the fraction of missing infor-
mation (g) for each imputed variable.12 For each
variable imputed, given the magnitude of g, m = 10
gave adequate power of imputation.12 We dropped
imputed values outside the range valid for the QRISK2
algorithm.
For the second method of substituting missing data
we took mean risk factor values from the 2008 Health
Survey for England (HSfE) in each year of age and sex
group. For patients with missing risk factor data we
entered thematchingmean value from theHSfE based
on the age and sex of the patient and assumed patients
with missing smoking data to be non-smokers.
Analysis
WecomparedCVD risk factors between ethnic groups
using t-tests (WilcoxonMann–WhitneyU-test for IMD),
using the following ﬁve categories (missing, white,
south Asian, black and other). We present age and
deprivation breakdowns, plus age-standardised risk
factor summaries for both men and women. We used
the direct method of standardisation, using eight
equal-age groups and the complete dataset as the
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standard. We applied the QRISK213 (after the 2010
update) and JBS210 risk scores to each imputed copy of
the data set, calculating the mean score across impu-
tations for each patient, for each method of impu-
tation. We summarised levels of the two risk scores
and diﬀerences overall in each sex/ethnicity group,
and the proportion designated as at high risk ( 20%)
– using direct age standardisation.
We compared the methods of data imputation. For
the two risk scores, we calculated the mean risk score
and the percentage of the population designated as
high risk using the multiple imputation and health
survey data. We assessed the agreement between the
methods of the high-risk status using Cohen’s Kappa,
quoting 95% conﬁdence intervals (CI).14 Outside the
population characteristics, we present the results for
those patients with incomplete (n = 63 607) data
recording to fully establish the impact of data impu-
tation. All analyses were carried out using Stata 11.1.
We obtained ethical approval for the use of anon-
ymised patient-level data from the London Research
Ethics Committee.
Results
Table 2 shows the characteristics of the study popu-
lation; the white population was more aﬄuent than
other ethnicities (Wilcoxon Mann–Whitney U-test
P<0.001 comparedwith all other ethnic groups), smok-
ing was higher in women (t-test P< 0.001 compared
with all ethnic groups). The south Asian and black
populations have higher levels of diabetes (t-test
P< 0.001 compared with all other ethnic groups)
and in the female population, black patients have the
highest levels of obesity (t-test P< 0.001 compared
with all other ethnic groups).
In the entire population (n = 127 724), using mul-
tiple imputation data, the mean QRISK2 score [8.4
(95% CI = 8.4–8.4)] was signiﬁcantly lower than JBS2
[11.1 (11.1–11.2)] with fewer patients designated as
being at high risk [n = 15 258; 11.9% (11.8–12.1)] and
n = 21377; 16.7% (16.5–16.9), respectively] (Table A1).
The QRISK2 score was lower in both sexes, and over
most ethnic groups, with the largest diﬀerence in men
of south Asian origin. Patients not of white, south
Table 1 Variables included in QRISK2 and JBS2 score, and levels of missing data
QRISK2 JBS2 % Missing
Agea x x 0.0
Sexa x x 0.0
Ethnicitya x c 34.3
Deprivation (Townsend score)a,b x 11.9
Smoking x x 3.2
Hypertensiona x 0.0
Diabetesa x x 0.0
Blood pressure x x 11.1
Cholesterol/HDL x x 44.6
Body mass index x 15.7
Family history of CVDa x c 28.6
Heart failure x 18.5
Chronic kidney diseasea x 18.5
Rheumatoid arthritis x 100
Atrial ﬁbrillation x 18.5
aVariables used in the multiple imputation of missing data. b Townsend score for QRISK2/IMD2007 for other analysis. c Not
included within the algorithm, but adjustment factors are added.
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Asian or black ethnicity had a higher QRISK2 score
than JBS2 in women.
In the population with missing risk factor data (n =
63 607), the multiple imputation method produces
similar estimates of risk using both scores, but lower
proportions of the population at high risk compared
with using HSfE estimates. Diﬀerences were, however,
relatively small. Using QRISK2 (Table 3), there were
10.3% at high risk using multiple imputation com-
pared with 11.7%using theHSfE estimates inmen; for
women this was 3.0% compared with 3.4%, respect-
ively (JBS2 risk score is shown in Table A2).
There were diﬀerences in mean risk scores and
proportion at high risk using the two methods by
sex and ethnic group. White men and women, south
Asian men and black women were more likely to be
designated as at high risk using National Health Survey
data but these diﬀerences were small. In designating
patients to be at high risk, the two methods showed a
strong agreement with high kappa values across all sex
and ethnic groups. In black men there was a signiﬁ-
cantly higher agreement between methods to other
ethnic groups.
Discussion
Principal ﬁndings
We compared the cardiovascular risk scores generated
for patients using two methods to substitute missing
risk factor data. One approach was methodologically
and computationally simple, using National Health
Survey data, whilst the second was more complex using
multiple imputation. Using multiple imputation the
risk score estimates were similar and there was a small
but signiﬁcantly lower prevalence of high-risk status.
Ethnic diﬀerences in risk scores were seen between the
methods, although these were again only small. Mul-
tiple imputation is regarded as an accurate method of
dealing withmissing data and is robust to large amounts
of missing data.8 It is, however, a more time-consum-
ing and complicated process than the use of default
values from survey data, and is less transparent to non-
statistically trained people. These small diﬀerences are
unlikely to be clinically signiﬁcant.
What is already known on this topic?
Evidence has grown supporting targeted screening for
CVD as both an eﬀective and cost-eﬀective approach.
Interrogating general practice data, Marshall et al
found that a large proportion of the patients eligible
for primary prevention therapy lie in those with the
highest estimated risk.15 Recent evidence suggests that
pre-stratiﬁcation of patient in the Health Check pro-
gramme may alleviate the need for complete de novo
risk factor recording.16
Modelling shows targeted screening as more cost-
eﬀective than a universal approach,3,4 with limited
value in recording new risk factor data in the whole
population.17 The call for targeted screening is not a
new one and there is growing evidence to support this
approach,18 a recent case-control study has shown the
strengths of using existing administrative data in the
USA to predict stoke.19 CVD risk factor recording is
not complete in patient medical records,5 but partial
data maintains accurate risk prediction.20
Limitations of the methods
Our data were extracted from the electronic medical
records of a large number of patients. They cover an
ethnically and socio-economically diverse population,
diﬀerent from those previously used to compare CVD
risk scores in theUK,21 and cover a large proportion of
the registered patients in one English PCT. We used
the recently updated version of the QRISK2 algor-
ithm, and the modiﬁed Framingham (JBS2) risk score
recommended as an alternative to QRISK2 in UK
national clinical guidance.22 Our data are timely and
accurately represent the level of cardiovascular risk in
a deprived, ethnically diverse population, although
may not represent risk in other settings.
We cannot compare the predictive accuracy of the
risk score as we were unable to link data to cardio-
vascular outcomes. The QRISK2 score may underesti-
mate risk, especially in minority ethnic groups,11 due
to the small ethnic minority populations in the deri-
vation data set. QRISK2 and its predecessor QRISK
do, however, predict risk more accurately in the UK
than Framingham risk scores.21 Aside from missing
data imputed in the study, our data set contained no
data on rheumatoid arthritis and had missing data for
atrial ﬁbrillation, CKD and heart failure, all of which
are variables in the QRISK2 score. These are not core
components of the algorithm and the risk score allows
them to be treated as absent if missing.11 There were
further missing data for the Townsend deprivation
score which were replaced with themedian score from
the PCT. Neither method of data imputation will fully
account for patient-level diﬀerences, it is likely those
with missing data will diﬀer from the remaining
population. Although we use national default risk
factor values as an exemplar, with primary care infor-
mation systems in England, general practice mean
values may prove easier to produce, and likely to be
more reliable.
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Call for further research
Our data add to work showing the eﬀectiveness of
targeted screening by demonstrating that simple data
methods can be used. In a UK setting, formal model-
ling to compare alternate CVD prevention strategies,
such as a targeted one, with the NHS Health Check
strategy is vital. Our dataset contains no data on CVD
endpoint, including CVD mortality. Analyses linking
methods of risk stratiﬁcation and the management of
missing risk factor data to predicted outcome will
further show the value of such methods.
Implications of ﬁndings for practice
CVD risk sores currently lie at the heart of one of
England’s foremost public health initiatives, the NHS
Health Check programme; they therefore have signiﬁ-
cant implications for patient care. In the UK, there is
currently a large national expenditure on a primary
prevention programme for CVD with spending esti-
mates between £180 million and £240 million per
year.23 Early evaluation of the programme has indi-
cated that uptake and subsequent referrals are more
limited than projected.24 This will limit overall eﬀec-
tiveness.25 If restricted patient involvement persists,
especially given the need for greater eﬃciency in health
spending, policy alternatives must be considered. Evi-
dence fromprevious studies, outlined above, indicates
that target CVD prevention is a viable alternative.
This, however, was never considered when planning
the NHS Health Check programme.23
CVD risk scores were designed as clinical tools,
however, they are also eﬀective at a population level,26
and are themost eﬃcientmethod of risk stratiﬁcation.20
Our ﬁndings demonstrate that a targeted screening
method using electronic medical records in English
primary care is easily implemented, and open to all
providers, regardless of experience in informatics. Even
if fully targeted screening is not adopted, the use of
simple data imputation and stratiﬁcation may create
eﬃciency savings within a universal programme. Evi-
dence, for example, suggests that pre-stratiﬁcation
may alleviate the need for cholesterol testing in all
patients eligible for aHealthCheck.16 TheNHSHealth
Checks is, internationally, the ﬁrst systematic, popu-
lation-wide CVD prevention programme. Other coun-
tries with strong primary care structures and well-
developed informatics may also consider the methods
of targeting outlined here.
Conclusion
Using existing medical record data for targeting
screening, missing data are inevitable. A simple method
of substituting missing data may be as eﬀective in
producing a CVD risk score as one using a complex
method. A targeted approach to CVD prevention
may be more cost-eﬀective than a universal approach,
and we demonstrated that it need not use complex
methods to overcome missing data.
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Appendix 1
Table A1 Age-standardised risk scores using the multiple imputation data in the total
population
Missing White South Asian Black Other Total
Female
Mean risk score
JBS2 6.6 7.6 8.1 7.6 7.7 7.4
QRISK 5.4 6.4 7.3 6.4 8.1 6.5
Diﬀerence
(95% CI)
1.25
(1.22–1.29)
1.21
(1.17–1.27)
0.81
(0.76–0.87)
1.21
(1.12–1.29)
-0.43
(–0.52– –0.33)
0.95
(0.92–0.97)
Proportion high
risk
JBS2 4.6 7.4 9.6 8.2 7.9 7.1
QRISK 3.8 6.7 9.8 6.9 11.7 7.1
Diﬀerence
(95% CI)
0.84
(0.59–1.1)
0.65
(0.34–0.96)
–0.2
(–0.56–0.17)
1.38
(0.78–1.97)
–3.85
(–4.4– –3.29)
0.02
(–0.14–0.17)
Male
Mean risk score
JBS2 13.1 14.2 20.4 13.8 14.4 15.1
QRISK 8.9 10.5 11.7 9.5 13.5 10.5
Diﬀerence
(95% CI)
4.11
(4.05–4.17)
3.66
(3.59–3.74)
8.71
(8.59–8.82)
4.35
(4.21–4.50)
0.93
(0.78–1.08)
4.63
(4.58–4.67)
Proportion high
risk
JBS2 21.0 24.4 40.6 23.9 25.6 26.7
QRISK 12.4 17.1 21.4 15.2 24.7 17.2
Diﬀerence
(95% CI)
8.66
(8.23–9.08)
7.32
(6.83–7.81)
19.2
(18.5–19.8)
8.68
(7.67–9.68)
0.91
(0.12–1.7)
9.6
(9.3–9.8)
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Table A2 Age-standardised JBS2 estimates using multiple imputation and HSfE data to
substitute missing data in patients with missing data
Missing White South Asian Black Other Total
Risk score
Male
HSE 12.8
(12.7–12.9)
13.8
(13.7–14.0)
19.2
(18.9–19.5)
13.7
(13.4–14.0)
13.8
(13.5–14.0)
14.0
(13.9–14.0)
IMP 12.6
(12.5–12.7)
13.3
(13.1–13.4)
18.6
(18.3–18.9)
12.7
(12.4–13.1)
13.4
(13.2–13.7)
13.6
(13.5–13.7)
Female
HSE 6.4 (6.3–6.4) 7.0 (6.9–7.1) 6.9 (6.7–7.1) 6.6 (6.4–6.8) 7.0 (6.8–7.2) 6.7 (6.6–6.7)
IMP 6.2 (6.1–6.2) 6.7 (6.6–6.8) 6.8 (6.6–7.0) 6.2 (6.0–6.4) 6.7 (6.5–6.9) 6.4 (6.4–6.5)
High risk
Male
HSE 21.7
(21.2–22.2)
24.7
(23.9–25.6)
37.3
(36.2–38.4)
23.8
(21.8–26)
23.5
(22.1–25.1)
24.5
(24.1–24.9)
IMP 20.1
(19.5–20.7)
21.4
(20.5–22.3)
36.2
(35–37.4)
21.1
(19–23.4)
22.6
(21.1–24.2)
22.6
(22.1–23.0)
Kappa 0.89
(0.87–0.90)
0.89
(0.88–0.89)
0.90
(0.90–0.91)
0.90
(0.89–0.91)
0.90
(0.90–0.91)
0.89
(0.89–0.90)
Female
HSE 3.4 (3.0–3.8) 5.2 (4.6–5.8) 6.5 (5.5–7.7) 5.0 (3.8–6.6) 5.5 (4.5–6.6) 4.5 (4.2–4.8)
IMP 2.8 (2.5–3.2) 4.2 (3.6–4.8) 5.2 (4.3–6.3) 3.6 (2.6–5.0) 4.6 (3.7–5.7) 3.6 (3.4–3.9)
Kappa 0.89
(0.88–0.90)
0.85
(0.84–0.86)
0.83
(0.82–0.83)
0.88
(0.88–0.89)
0.88
(0.88–0.89)
0.87
0.86–0.88)
